Neoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Rectal Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Rectal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hebei Medical University Fourth Hospital, Shijiazhuang, Hebei, China
Contact: Study coordinator (Fengpeng Wu, Professor) · 15032818011

Study leads

Fengpeng Wu, Professor
Principal Investigator
Hebei Medical University Fourth Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients

Metastatic Colorectal Cancer

Abroad (travel likely)RecruitingPHASE2

Shanghai, China

Immunotheray Combined With Simvastatin and Target Therapy and Chemotharepy for Advanced Colorectal Cancer

Metastatic Colorectal Cancer

Abroad (travel likely)RecruitingPHASE2

Nanjing, China · Nanjing, China

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

Colorectal Cancer

Abroad (travel likely)RecruitingPHASE2

Huntsville, United States · Fullerton, United States

Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment

Colon Carcinoma · Colorectal Carcinoma · Rectal Carcinoma

Abroad (travel likely)RecruitingPHASE2

Atlanta, United States · Atlanta, United States